HLA-G and chronic kidney disease: β2-microglobulin is considered as a prototypic middle molecule and is traditionally used as a marker of middle molecule removal, although both in pre-dialysis CKD [335] as in dialysis patients [336], β2-microglobulin behavior did not necessarily conform with that of other middle molecules.